interesting article, page-2

A real positive with this company is that the manufacturing costs are low. This will ensure very healthy profits as the customer base continues to increase.

When you consider that financially the company is in a strong position already it all goes well for the future.

Its not like some new fangle dangled idea that has never been tested, its in the market with a sound customer base, is selling and making a solid profit with more revenue already booked in for the next 5 years with one pharmaceutical in a brand new market.
Not too many small cap companies in this position.

A very different scenario to investing in some tin pot mining company, not knowing whether they will make hit and in the meantime the funds being chewed up on "exploration"